KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Construction in Progress (2016 - 2025)

Historic Construction in Progress for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $163.1 million.

  • Biogen's Construction in Progress fell 4711.41% to $163.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $163.1 million, marking a year-over-year decrease of 4711.41%. This contributed to the annual value of $163.1 million for FY2025, which is 4711.41% down from last year.
  • Per Biogen's latest filing, its Construction in Progress stood at $163.1 million for Q4 2025, which was down 4711.41% from $308.4 million recorded in Q4 2024.
  • Over the past 5 years, Biogen's Construction in Progress peaked at $1.9 billion during Q1 2021, and registered a low of $163.1 million during Q4 2025.
  • For the 5-year period, Biogen's Construction in Progress averaged around $754.1 million, with its median value being $711.1 million (2022).
  • Its Construction in Progress has fluctuated over the past 5 years, first surged by 1538.36% in 2022, then crashed by 6838.22% in 2024.
  • Quarter analysis of 5 years shows Biogen's Construction in Progress stood at $770.3 million in 2021, then grew by 15.38% to $888.8 million in 2022, then increased by 9.74% to $975.4 million in 2023, then tumbled by 68.38% to $308.4 million in 2024, then plummeted by 47.11% to $163.1 million in 2025.
  • Its last three reported values are $163.1 million in Q4 2025, $308.4 million for Q4 2024, and $975.4 million during Q4 2023.